BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1
76592 results:

  • 1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
    Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
    Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Two cases of inflammatory myofibroblastic tumor treated with targeted drugs: A case report.
    Liu M; Zhu D
    Medicine (Baltimore); 2024 May; 103(21):e38136. PubMed ID: 38787978
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
    Zhong Q; Yan Y; Li S
    Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
    Salem AH; Menon RM
    Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
    Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
    BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers.
    Grant WB
    Adv Food Nutr Res; 2024; 109():271-314. PubMed ID: 38777416
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CAR T-Cell Immunotherapy in Minority Patients with lymphoma.
    Ghilardi G; Williamson S; Pajarillo R; Paruzzo L; Chen L; Grady C; Doucette A; Nemecek E; Gabrielli G; Barta SK; Svoboda J; Chong EA; Yelton R; Nasta SD; Landsburg DJ; Ugwuanyi O; Chen AI; Schachter L; White G; Ballard HJ; Weber E; Curley C; Porter DL; Garfall AL; Hwang WT; Guerra CE; Maziarz RT; Schuster SJ; Ruella M
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300213. PubMed ID: 38776868
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
    Nakamura N; Jo T; Arai Y; Kitawaki T; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
    Clin Exp Med; 2024 May; 24(1):105. PubMed ID: 38771501
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.
    Al-Thiabat H; Abu-Aqoulah A; Kanaan D; Matalka MI; Al-Sweedan S
    Am J Case Rep; 2024 May; 25():e943597. PubMed ID: 38769718
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
    Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
    BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
    Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
    J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnosis of Angioimmunoblastic T Cell lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report.
    Khatri JK; Tahboub I; Anwar K; Masoudi M; Graffeo V; Jamil MO
    J Investig Med High Impact Case Rep; 2024; 12():23247096241231645. PubMed ID: 38761096
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development of EBV Related Diffuse Large B-cell lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
    Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW
    J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
    Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
    Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3830.